Booster Therapeutics
Booster Therapeutics is pioneering a new class of medicines that activate proteasomes (the cell’s natural quality control machinery) to treat a range of complex indications. The company is developing a multi-disease pipeline, with an initial focus on neurodegenerative diseases associated with impaired proteasome function.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
11
1 to 10 range
Open roles
—
no listings
Distinct roles
3
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 4 verified contacts at Booster Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- DR
Diogo R. Feleciano
Co-founder & COO · Other
EmailPhone - EG
Emanuele Gabellieri
Head of Medicinal Chemistry · Other
EmailPhone - LL
Letizia Lazzaro
Compound & Data Manager Scientific Consultant · Other
EmailPhone
Showing 3 of 4 verified contacts
Top roles at Booster Therapeutics
3 distinct titles indexed · top 3 shown.
- 1co-founder & coo
- 1compound & data manager scientific consultant
- 1head of medicinal chemistry
Sign up to unlock all 4 contacts at Booster Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Booster Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.